NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
Go back to NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight| (NASDAQ: ELAB) | Delayed: 4.42 -0.36 (7.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $ | |||
| Open | $4.68 | 52 Week Low | $ | |||
| Day High | $4.74 | P/E | N/A | |||
| Day Low | $4.35 | EPS | $ | |||
| Volume | 21,904 | |||||
| (NASDAQ: ELAB) | Delayed: 4.42 -0.36 (7.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $ | |||
| Open | $4.68 | 52 Week Low | $ | |||
| Day High | $4.74 | P/E | N/A | |||
| Day Low | $4.35 | EPS | $ | |||
| Volume | 21,904 | |||||

